Log in
Enquire now

List of Lentigen patents

List of Lentigen patents
List of Cisbay patents
List of Lifenet Health patents
List of Morphy Richards patents
List of companies in WndrCo's investment portfolio
List of digital transformation patents
Patents where
Current Assignee
Name
is
LentigenLentigen
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10894819 Compositions and methods for treating HIV/AIDS with immunotherapy

Patent 10894819 was granted and assigned to Lentigen on January, 2021 by the United States Patent and Trademark Office.

Lentigen
Lentigen
Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
10894819
January 19, 2021
‌
US Patent 11208455 Compositions and methods for treating cancer with DuoCARs

Patent 11208455 was granted and assigned to Lentigen on December, 2021 by the United States Patent and Trademark Office.

Lentigen
Lentigen
Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
11208455
December 28, 2021
‌
US Patent 11242389 Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy

Patent 11242389 was granted and assigned to Lentigen on February, 2022 by the United States Patent and Trademark Office.

Lentigen
Lentigen
Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
11242389
February 8, 2022
‌
US Patent 10421810 Chimeric antigen receptors and methods of use

Patent 10421810 was granted and assigned to Lentigen on September, 2019 by the United States Patent and Trademark Office.

Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
10421810
September 24, 2019
‌
US Patent 10442867 Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

Patent 10442867 was granted and assigned to Lentigen on October, 2019 by the United States Patent and Trademark Office.

Lentigen
Lentigen
Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
10442867
October 15, 2019
‌
US Patent 11590169 Compositions and methods for treating cancer with anti-CD123 immunotherapy

Patent 11590169 was granted and assigned to Lentigen on February, 2023 by the United States Patent and Trademark Office.

Lentigen
Lentigen
Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
11590169
February 28, 2023
‌
US Patent 11052112 Compositions and methods for treating cancer with anti-BCMA immunotherapy

Patent 11052112 was granted and assigned to Lentigen on July, 2021 by the United States Patent and Trademark Office.

Lentigen
Lentigen
Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
11052112
July 6, 2021
‌
US Patent 10183993 Compositions and methods for treating cancer with anti-mesothelin immunotherapy

Patent 10183993 was granted and assigned to Lentigen on January, 2019 by the United States Patent and Trademark Office.

Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
10183993
January 22, 2019
‌
US Patent 10689431 Compositions and methods for treating cancer with DuoCARs

Patent 10689431 was granted and assigned to Lentigen on June, 2020 by the United States Patent and Trademark Office.

Lentigen
Lentigen
Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
10689431
June 23, 2020
‌
US Patent 10639329 Method to treat cancer with engineered T-cells

Lentigen
Lentigen
Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
10639329
May 5, 2020
‌
US Patent 10822412 Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy

Patent 10822412 was granted and assigned to Lentigen on November, 2020 by the United States Patent and Trademark Office.

Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
10822412
November 3, 2020
‌
US Patent 11802142 Compositions and methods for treating cancer with DuoCARs

Patent 11802142 was granted and assigned to Lentigen on October, 2023 by the United States Patent and Trademark Office.

Lentigen
Lentigen
Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
11802142
October 31, 2023
‌
US Patent 11680103 Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

Lentigen
Lentigen
Lentigen
Lentigen
United States Patent and Trademark Office
United States Patent and Trademark Office
11680103
June 20, 2023
13 results
0 selected
13 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us